CK-4021586
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CK-4021586, covering 2025-05-01 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF [Phase 2]